Peter H. Vlasses

Effects of Finasteride (MK-906), a 5<i>α</i>-Reductase Inhibitor, on Circulating Androgens in Male Volunteers*

Glenn J. Gormley, Elizabeth Stoner, Roger S. Rittmaster et al. · The Journal of Clinical Endocrinology & Metabolism · 1990 · 161 citations

Medicine, Endocrinology, Pharmacology +17

Norfloxacin disposition after sequentially increasing oral doses

B N Swanson, V K Boppana, Peter H. Vlasses et al. · Antimicrobial Agents and Chemotherapy · 1983 · 147 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Clinical pharmacology and economics of recombinant human erythropoietin in end-stage renal disease

Anatole Besarab, Kristen K. Flaharty, A. J. Erslev et al. · Journal of the American Society of Nephrology · 1992 · 140 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men

Kristen K. Flaharty, J. Jaime, Allan J. Erslev et al. · Clinical Pharmacology & Therapeutics · 1990 · 126 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +10

Effects of Gender, Posture, and Age on Gastric Residence Time of an Indigestible Solid: Pharmaceutical Considerations

Parviz Mojaverian, Peter H. Vlasses, Paul E. Kellner et al. · Pharmaceutical Research · 1988 · 118 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +14